Home / Inspections / 1305506

FDA Inspection 1305506 — University of Texas MD Anderson Cancer Center

University of Texas MD Anderson Cancer Center — FEI 3010547404

The FDA completed an inspection of University of Texas MD Anderson Cancer Center on February 20, 2026 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 20, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Houston, TX (United States)

Facility

Other inspections at this facility

  • 1250648 (NAI Mon Sep 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1165594 (VAI Thu Mar 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1115530 (NAI Thu Dec 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources